Research Site

Chapecó 89812-220

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Chronic Obstructive Pulmonary Disease (COPD)

Studies at this site

• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy — Recruiting now
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006) — Recruiting now